OneAlphaMed built an asynchronous, multilingual advisory platform that engaged 850+ top-tier oncologists across 12 time zones — with zero scheduling conflicts and a 92% participation rate.
Industry / Specialty
Pharmaceutical & Healthcare
Scale / Audience
15,000+ HCPs
Core Solutions
Co-created Certification
Time to Value
Pan-India Deployment
Stop funding clicks. Start building undisputed credibility for your brand today.
A leading oncology brand struggled with plummeting attendance at their annual global advisory boards due to severe KOL burnout and complex time zone logistics. AlphaMed engineered an asynchronous, staggered video-learning and feedback platform that allowed KOLs to engage, review data, and collaborate on their own schedules. The result: 850+ global KOLs engaged, a 92% participation rate, 12 languages supported, and zero scheduling conflicts across the US, EU, and APAC regions.
Coordinating live sessions across the US, EU, and APAC resulted in low attendance, poor engagement, and diminishing returns on high-cost advisory events.
Scheduling live advisory boards that satisfied oncologists in North America, Europe, and Asia-Pacific simultaneously was functionally impossible. A single 'global' session always alienated at least one region, with early-morning or late-night slots dramatically reducing participation quality and the depth of scientific exchange.
Top-tier oncologists — the very experts whose insights carry the most value — were suffering from acute 'Zoom fatigue.' Flooded with invites from multiple pharmaceutical companies, they were systematically declining standard live webinar invitations. The brand was losing access to its most critical external scientific advisors.
Feedback collected from existing advisory boards was fragmented and unstructured — scattered across email chains, chat logs, and handwritten notes. Converting this raw, disparate input into a coherent scientific narrative for internal teams consumed enormous resources and still produced unreliable outputs.
OneAlphaMed transformed the global advisory board from a single, live event into a rich, multi-week asynchronous collaboration platform.
AlphaMed pre-produced high-fidelity, modular clinical presentations — including complex data visualizations, animated mechanism-of-action explainers, and expert commentary. These were translated and localized for each target region, ensuring every KOL received content in their preferred scientific context and language.
KOLs were given a structured 7-day engagement window to log into the secure platform, review the pre-loaded clinical data at their own pace, and leave timestamped video or detailed text feedback at any point in the module. This respected their clinical schedules while ensuring all voices were heard with equal weight.
An intelligent dashboard aggregated all KOL feedback — capturing sentiment analysis, thematic clustering of scientific opinions, and individual commentary — into a single, comprehensive report for the brand's Medical Affairs team. This replaced weeks of manual synthesis with a structured deliverable available within 48 hours of the engagement window closing.
By allowing the world’s leading oncologists to engage with cutting-edge trial data on their own terms — without interrupting clinical hours or crossing time zones — AlphaMed established a new gold standard for global pharmaceutical advisory boards. The asynchronous model didn’t just solve a logistical problem; it fundamentally elevated the quality and depth of the scientific exchange.
The platform delivered unprecedented global reach and a 92% engagement rate — a metric that most live advisory boards would consider impossible.
The initiative delivered a clear, strategic win for every stakeholder — creating a model that has since been adopted as the brand's global standard for all future advisory engagements.
Gained the flexibility to engage with cutting-edge trial data on their own schedule without interrupting clinical hours. This led to a dramatic improvement in the depth and quality of scientific contributions, as experts contributed insights when mentally prepared rather than when logistically forced to attend.
Received highly structured, easily exportable qualitative feedback — organized by theme, region, and scientific sentiment — replacing the chaotic, unreliable transcripts from previous live sessions. The structured insights directly informed the brand's Phase IV strategy and label messaging.
Restored and deepened relationships with high-value scientific experts by visibly and demonstrably respecting their time. The asynchronous model also dramatically reduced the per-KOL engagement cost while simultaneously increasing the richness of the insights obtained.
The platform includes mandatory engagement checkpoints embedded throughout each module. KOLs must complete specific interactive elements — clinical data interpretation tasks, opinion-capture questions, and video response prompts — before unlocking subsequent sections. The system logs granular interaction data, including time spent on each slide, to validate genuine engagement.
Yes. The hub features enterprise-grade AES-256 encryption at rest and in transit, individual NDA-gated access paths, and a strict role-based permission system. Specific modules can be restricted to select KOLs based on their advisory agreement level, ensuring that data confidentiality is maintained across all geographies.
Honorarium disbursements are automatically triggered upon the verified completion of all mandatory engagement modules. The system generates a digital completion certificate and a timestamped activity log for each KOL, which feeds directly into our compliant honorarium processing workflow — ensuring seamless, fully-documented compensation.
+91 9811660635
info@onealphamed.com
2414, Ground Floor, Aravali Vihar, Sector 49 Faridabad, Haryana – 121001 India
Copyright © 2026 OneAlphaMed. All Rights Reserved.